Oxibutinina hydrochloride | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Oxibutinina Hydrochloride
Europe

Evonik

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

Oxibutinina hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 13 USDMF, 11 CEP/COS, 3 JDMF, 3 EU WC, 1 KDMF, 12 NDC API, 9 Listed Suppliers, $ API Reference Price

27 API Suppliers
13 USDMF
11 CEP/COS
3 JDMF
3 EU WC
1 KDMF
12 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

85 FDF Dossiers, 61 FDA Orange Book, 5 Europe, 9 Canada, 4 South Africa, 6 Listed Dossiers

85 FDF Dossiers
61 FDA Orange Book
5 Europe
9 Canada
4 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TRANSDERMAL - 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TRANSDERMAL - 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 7 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 7 Kirsch Pharma, 1 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 30 BASF, 2 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 8 Ideal Cures, 5 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 40 Direct Compression, 36 Controlled & Modified Release, 33 Granulation, 31 Disintegrants & Superdisintegrants, 30 Solubilizers, 30 Parenteral, 29 Taste Masking, 29 Thickeners and Stabilizers, 26 Film Formers & Plasticizers, 23 Lubricants & Glidants, 19 Topical, 19 Chewable & Orodispersible Aids, 13 Co-Processed Excipients, 9 Emulsifying Agents, 7 Rheology Modifiers, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

71 Fillers, Diluents & Binders
63 Coating Systems & Additives
40 Direct Compression
36 Controlled & Modified Release
33 Granulation
31 Disintegrants & Superdisintegrants
30 Solubilizers
30 Parenteral
29 Taste Masking
29 Thickeners and Stabilizers
26 Film Formers & Plasticizers
23 Lubricants & Glidants
19 Topical
19 Chewable & Orodispersible Aids
13 Co-Processed Excipients
9 Emulsifying Agents
7 Rheology Modifiers
6 Surfactant & Foaming Agents
6 API Stability Enhancers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

17 News #PharmaBuzz

17 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 12 Regulatory FDF Prices

34 US Medicaid Prescriptions
12 Regulatory FDF Prices

MARKET PLACE

10 APIs

10 APIs

PATENTS & EXCLUSIVITIES

3 US Patents, 6 Health Canada Patents

3 US Patents
6 Health Canada Patents

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 642 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 1Arafarma Group Sa

02 1Cheplapharm Arzneimittel Gmbh

03 1EG SPA

04 1Farco-Pharma Gmbh

05 1MYLAN SPA

filter Active Ingredients Reset all filters

5 All

01 3Oxybutynin Hydrochloride

02 2Oxybutynin hydrochloride

filter Dosage Form Reset all filters

5 All

01 1Intravesical Solution

02 3Tablet

03 1Tablets

filter Country Reset all filters

5 All

01 2Italy

02 3Spain

filter Brand Name Reset all filters

5 All

01 1Ditropan

02 1Dresplan Tablets

03 1OXYBUTYN EG

04 1OXYBUTYN HYDROCHLORIDE MYLAN GENERICS

05 1Vesoxx

List of Suppliers

Product Main Page

01

Arafarma Group Sa

The MedTech Conference

Not Confirmed

Arafarma Group Sa

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Oxybutynin Hydrochloride

Brand Name : Dresplan Tablets

Dosage Form : Tablet

Dosage Strength :

Packaging :

Approval Date : 1999-02-01

Application Number : 62205

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Cheplapharm Arzneimittel Gmbh

The MedTech Conference

Not Confirmed

Cheplapharm Arzneimittel Gmbh

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Oxybutynin Hydrochloride

Brand Name : Ditropan

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date : 1987-01-01

Application Number : 57185

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EG SPA

The MedTech Conference

Not Confirmed

EG SPA

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Oxybutynin hydrochloride

Brand Name : OXYBUTYN EG

Dosage Form : Tablet

Dosage Strength : 5mg

Packaging : 30 UNITS 5 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MYLAN SPA

The MedTech Conference

Not Confirmed

MYLAN SPA

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Oxybutynin hydrochloride

Brand Name : OXYBUTYN HYDROCHLORIDE MYLAN GENERICS

Dosage Form : Tablets

Dosage Strength : 5 mg

Packaging : 30 UNITS 5 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Farco-Pharma Gmbh

Country

The MedTech Conference

Not Confirmed

Farco-Pharma Gmbh

Country

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Oxybutynin Hydrochloride

Brand Name : Vesoxx

Dosage Form : Intravesical Solution

Dosage Strength : 1MG

Packaging :

Approval Date : 2023-09-04

Application Number : 85899

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!